30 closest matches · ranked by relevance
Breast Cancer
Primary: Knowledge of Breast Cancer Risk Factors — 48.9; 56.4 units on a scale
HIV · Opioid Dependence
Primary: Demonstrated Drug Risk Reduction Skills (0-100%) — 40.60; 42.75 Percentage of correct steps
Neoplasms, Prostate
Primary: Number of Participants With Biopsy-detectable Prostate Cancer at Years 2 and 4 (Crude Rate Approach) — 578; 435; 280; 224 participants — p=<0.0001
HIV Infections · Episodic Substance Use
Primary: Total Unprotected Anal Intercourse Events (Exclusive of Those Events With a Primary HIV-negative Partner) — 4.23; 3.91; 3.41; 2.05 Self reported events in past 3 months
Accidental Falls · Wounds and Injuries
Primary: First Adjudicated Serious Fall-Related Injury — 4.87; 5.34 events per 100 person years of follow-up — p=0.245
Health Behavior
Primary: HIV Knowledge Confidence — 42.9; 40.5 units on a scale — p=<.001
Cocaine Use Disorder
Primary: Endothelin-1 Levels — 2.15; 2.063; 1.956 pg/ml
Sexual Assault
Primary: Days Per Month Hazardous Drinking — 7.54; 10.40; 1.97; 1.53 Days per Month Hazardous Drinking — p=<0.99
Dementia · Alzheimer Disease
Primary: Cognitive Change — 0.34; 0.19 z-score — p=0.008
Methicillin-resistant Staphylococcus Aureus
Primary: Main Outcome: Patients With Nosocomial MRSA Clinical Cultures — 0.92; 0.75; 0.63 hazard ratio — p=0.01
Type 2 Diabetes Treated With Insulin · Hypoglycemia · Primary Health Care
Primary: Clinical Outcome: Number of Participants With Glycemic Regimen De-prescribing — 34; 21 Participants
Hypertension · Hyperlipidemia · Diabetes
Primary: Predicted Annual Rate of Change in 10-year Risk of Fatal or Nonfatal Heart Attack or Stroke — -0.59; 1.66 annualized change in 10 year % cv risk — p=<0.05
Diffuse Large B-cell Lymphoma
Primary: Number of Participants With Local Control — 61 Participants
Hypercholesterolemia · Coronary Artery Disease · Dyslipidemia
Primary: Comparative Outcomes: Intervention Group LDL Reduction Compared to Control Group LDL Reduction — 11.0; 11.1 % of patients with major LDL reduction — p=0.99
Geriatric Assessment · Frail Elderly · Skilled Nursing Facilities
Primary: Total Number of Medications — 15; 13; 15.5; 14 Medications — p=0.006
Sexual Violence
Primary: Change From Baseline in Sexual Violence Victimization at 6-months Follow-up — 5.64; 5.68; 5.52; 8.15 score on a scale — p=.0002
Sexually Transmitted Infection
Primary: Change in Frequency of Recent Dual Method Use — 3.17; 3.45 score on a scale — p=.177
HIV
Primary: Proportion of Patients Free of Treatment Failure (Noncompleter = Failure) at 24 Weeks. — 30; 31; 0; 0 Participants
Children, Only · Risk Reduction · Environmental Exposure
Primary: Decrease in Child Care Center Pesticides — 1.95; 1.87; 0.59; 0.53 log10(ng/g) — p=<0.05
Drug Use Disorders · Hepatitis C · Harm Reduction
Primary: Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale — 1.26; 1.07; 1.12; 1.03 score on a scale — p=0.84
Adverse Drug Events
Primary: Health Services Utilization 3 Months Following Hospital Discharge — 3.33; 3.40 Health Services Utilizations — p=.87
HIV · HIV Infections
Primary: Combined HIV/STI 12-month Incidence Rates of HIV, Syphilis, Chlamydia, Gonorrhea and Trichomonas Vaginalis. — 65.02; 67.66; 35.02; 54.04 incidence density per 100 person…
Post-operative Infections
Primary: Presence of Bacterial IV Stopcock Lumen Contamination — 41; 32 percent stopcock contamination rate
Substance-Related Disorders
Primary: Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task — 1.50; 1.45; 1.47; 1.45 Cigarettes (log transformed)
Diagnostic Errors
Primary: Number of Adolescents Diagnosed With Depression Seen in Well Child Visits — 233; 443 Participants — p=<0.0001
Cardiovascular Diseases · Hypertension · Hyperlipidemias
Primary: New Participation in MOVE! (Among Women Aged 65 and Older) — 1.09 Odds Ratio — p=.003
Chronic Disease · Mental Disorder · Health Behavior
Primary: Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke — 14.2; 20.8 percentage of annual rate of change
Arrhythmias, Cardiac
Primary: Cumulative Dose Area Product (DAP) Value — 8.8; 15.3 Gy*cm^2 — p=<0.0001
HIV Infections · Sexually Transmitted Diseases
Primary: Efficacy of Internet-based Program for Increasing Condom Use With Non-main Sex Partners — .68; .56 percentage of sex acts protected by cond
Anterior Cruciate Ligament Injury
Primary: Change in Peak Knee Extension Moment Symmetry — 50.1; 44.2; 44.6; 40.6 % Symmetry